The table below shows SUPERNUS PHARMACEUTICALS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
$74.56M
$77.91M
$83.78M
$87.22M
-
$52.46M
Gross profit
-
-
-
-
-
-
R&D
$106.23M
$108.80M
$91.59M
$74.55M
$90.47M
$75.96M
SG&A
$485.56M
SUPN annual revenue (10-K history)
SUPERNUS PHARMACEUTICALS, INC. reported annual revenue of $718.95M for fiscal year 2025. That is up 8.6% from $661.82M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $215.00M (FY 2016) to $718.95M. Figures come from the company's audited annual reports as filed with the SEC.